|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00314 SIPAI HEALTH
Nominal 
5.440 +0.410 (+8.151%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,363,780 | -3.043% | 4,712,107 | 4,119,478 | 3,473,930 | 2,699,647 |
| Cost of Sales | (2,134,849) | -3.830% | (4,297,409) | (3,782,126) | (3,190,481) | (2,512,787) |
| Gross Profit | 228,931 | 4.971% | 414,698 | 337,352 | 283,449 | 186,860 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (3,291) | 79.934% | (9,965) | (780,726) | (3,054,835) | (662,675) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (157) | -- | (412) | 331 | 137 | (65) | |
| Profit / (Loss) before Taxation | (75,159) | -13.309% | (245,666) | (1,368,442) | (3,747,678) | (1,040,850) | |
| Taxation | 508 | -- | (1,041) | (3,322) | (825) | (1,179) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,551) | -29.178% | (9,061) | 1,192 | 8,048 | (752) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (78,202) | -15.293% | (255,768) | (1,370,572) | (3,740,455) | (1,042,781) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (8,661) | -51.709% | (27,851) | (13,208) | (6,682) | 2,391 |
| Depreciation & Amortisation | 23,853 | -11.360% | 52,968 | 49,423 | 53,882 | 47,711 |
| Directors' Emoluments | -- | -- | 5,783 | 137,580 | 121,029 | 52,124 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -12.000 | -14.286% | -40.000 | -1,219.000 | -3,761.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.207) | (1.619) | (6.254) | -- |
| NBV per share ($) | 1.962 | -- | 2.126 | 2.407 | -- | -- |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -78,202 |
| %Change | -15.293% |
| EPS / (LPS) | RMB -0.120 |
| NBV Per Share (¥) | RMB 1.962 |